admin

The Maryland Economic Development Association (MEDA) is proud to announce the winners of the 2020 MEDA Awards. The 2020 awards, sponsored by Miles & Stockbridge P.C., recognize the exceptional people, programs and projects that bring economic prosperity to Maryland.

“We’d like to thank all who submitted a nomination for recognizing such deserving programs, projects and individuals, and our awards judges for their hard work determining the winners,” says Pamela Ruff, MEDA executive director. “The 2020 winners exemplify the Maryland communities that are going above and beyond when it comes to economic expansion and prosperity.”

CEL-SCI Corporation (NYSE:CVM) announces that it is developing an immunotherapy with the potential to treat the COVID-19 coronavirus using its patented LEAPS peptide technology. The LEAPS peptides will utilize conserved regions of coronavirus proteins to stimulate protective cell mediated T cell responses and reduce viral load. The LEAPS peptide technology can be used to construct immunotherapeutic peptides that exhibit both antiviral and anti-inflammatory properties. Consequently, these products not only target the virus infection against which they are directed, but also elicit the appropriate protective response(s) against it.

Who runs the healthcare world? Women make 80% of all buying decisions and make up over 70% of the healthcare workforce—yet in 2020 we still do not have an equal voice in the ranks of leadership.

Diversity is also an issue when it comes to venture capital. Female entrepreneurs continue to struggle to raise as much capital as their male counterparts. Although capital investment in all-female founding teams hit an all time high of $3.3 billion in 2019, it represented only 2.8% of capital invested across the entire U.S. startup ecosystem.

Join JLABS for an evening panel discussion as we tackle these issues, and discuss avenues for capital, while forging a path forward for two of the most prohibitive factors at play: a lack of a robust network of female mentors and lack of investment dollars in female-led startups. 

We would like to invite you to join leading companies from the Northern Powerhouse region of England for a morning of presentations and networking. The delegation is visiting the Capital Region to help build relationships with key decision makers and build close trade and collaboration ties.

Over the past year, the Maryland Department of Commerce has continued to foster business growth throughout the state, by simplifying the process of starting a business, prioritizing customer service, and investing in our innovative companies.

During fiscal year 2019, the department provided financial assistance to 167 different economic development projects statewide, from Kite Pharma in Frederick to Smithfield Foods in Cecil County, bringing in a total capital expenditure of $630.5 million. More than 70 of these projects fell under the small, minority, and women-owned business category, according to the recently released annual report. 

“Philadelphia was an innovation and investment backwater,” but Ajay Raju says it’s headed for venture capital’s mainstream, and he’s personally setting up the partnerships to make it happen, pledges the real estate finance lawyer and chairman of the law firm Dilworth Paxson.

Image: ANDREW THAYER / FILE PHOTOGRAPH

Pennsylvania’s Independent Fiscal Office has suggested making the Keystone Innovation Zone (KIZ) tax credit refundable, which would eliminate the portion of the tax credit going to tax brokers and increase the funding available to target businesses. Other proposed changes would strengthen the applicant review process and expand data collection to improve program accountability. 

(Rockville, MD, February 25, 2020) Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received $850K from the National Science Foundation (NSF) to advance our understanding of how fungi like powdery mildew infect plants including food source crops, and how plants fight back. IBBR Fellow Dr. Shunyuan Xiao (Professor, Department of Plant Sciences and Landscape Architecture, University of Maryland College of Agriculture & Natural Resources) is the principal investigator on the award.

RESEARCH TRIANGLE PARK, N.C. and MANCHESTER, N.H., Feb. 24, 2020 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) and DEKA Research & Development Corp. today announced receipt of an additional 510(k) clearance by the U.S. Food and Drug Administration (FDA) related to the Unity Subcutaneous Delivery System for Remodulin® (treprostinil) Injection, also referred to as the Remunity™ pump, enabling United Therapeutics to launch the system using drug reservoirs that have been prefilled by specialty pharmacies.

GAITHERSBURG, Md., Feb. 26, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced progress in its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19. Novavax has produced and is currently assessing multiple nanoparticle vaccine candidates in animal models prior to identifying an optimal candidate for human testing, which is expected to begin by the end of spring 2020.